While Trump's strategy to lower prices is a step in the right direction, only Congress can deliver comprehensive reform that benefits all Americans
Gregg Girvan
It’s not every day that a professional sportswriter ends up as a health care wonk. But perhaps it should happen more often.
After all, both sports and health care traffic in reams of statistics, data that can be both used — and misused — to assess the performance of individuals and groups. And that’s where FREOPP Resident Fellow Gregg Girvan comes in.
“In sports, I can calculate a player’s career statistics, which may seem impressive at first, but may simply be the product of a long career rather than outstanding performance,” Gregg says. “In the same way, if we’re not careful to provide context, data and statistics can lead to poor decisions and policy outcomes.”
Gregg grew up in West Palm Beach, Florida, and attended the University of Florida, where he became the sports editor of the Independent Florida Alligator while double-majoring in political science and microbiology. He also covered University of Florida sports for the Tampa Tribune and the Palm Beach Post. “Despite being a UF student, my experience covering the Gators taught me the importance of putting my fandom aside and to report the facts without bias. It’s a lesson I have carried with me through my policy career, although — let’s face it — I’ve since allowed myself to bleed orange and blue again!”
After serving a mission in Berlin for the Church of Jesus Christ of Latter-Day Saints, Gregg began his transition into think tankery by obtaining a Master’s degree in public policy from Brigham Young University. He went on to serve in a number of health care policy roles at the Utah Office of Consumer Health Services, the Heritage Foundation, the Congressional Research Service, Booz Allen Hamilton, the Utah Office of Legislative Research & General Counsel, and the Texas Sunset Advisory Commission.
It was in these roles that Gregg reveled in his ability to delve into the unglamorous details of public policy work. For example, at his last stop before FREOPP, Gregg helped Texas save $465,000 a year by reducing wasteful spending in the state’s motorcycle safety program.
Gregg’s relationship to FREOPP’s mission is personal, because his family is no stranger to medical and financial difficulties. At one point, his children had to enroll in Medicaid, and the family often found it difficult to obtain the care they needed. “We had one provider in particular that dropped our Medicaid coverage without warning, which resulted in a disruption of care for our children when they needed it most. With Medicaid, you’re thinking you have coverage that’s ‘free,’ but nothing is free. There are always trade-offs.”
But the experience also highlighted for Gregg the importance and value in helping every American find affordable, high-quality health insurance. “Most of us can agree that health coverage for every American is a good thing. The real question is how we get there. Do we default to a one-size-fits-all system with little to no choice, or do we deliver universal coverage by harnessing personalized options and innovation and competition? I believe the latter gives us the best chance of success that’s sustainable — not just for my generation, but for my children’s generation and beyond.”
Gregg, who taught himself the R programming language, is FREOPP’s designated quant guy, the one who we most lean on for data-heavy research. “For the longest time, I felt alone in my view that we could achieve universal coverage and affordable health care through free markets. At FREOPP, I’ve found my home. And I’m proud that the research we produce here will help us achieve these goals.”
Gregg and Ashley live in the Austin suburbs with their three children, all of whom also bleed orange and blue.
Gregg Girvan
Attempts to lower drug prices leave intact a broken patent system that too often prioritizes profits over progress
Exorbitant drug prices burden American patients and taxpayers in an unfree market
Site-neutral billing fosters an environment where health care is driven by the needs of patients, not the location of service delivery
A new book offers a pathway to strengthen health coverage for today’s enrollees and preserve it for future generations
Europe designates all biosimilars as interchangeable with original biologics. It’s time for the United States to do the same
Biden’s proposed fix to the family glitch may work in the short term, but lawmaking through executive order and regulatory interpretation is vulnerable to policy reversals in subsequent administrations
The most consequential part of the decision memo clarified Medicaid's responsibilities in covering the drug